...
首页> 外文期刊>Bioorganic and medicinal chemistry >Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification
【24h】

Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification

机译:分子简化设计的半胱氨酸蛋白酶Cruzain和RhodeSain潜在抑制剂的合成与生物学评价

获取原文
获取原文并翻译 | 示例
           

摘要

Analogues of 8-chloro-N-(3-morpholinopropyl)-5H-pyrimido[5,4-b]indol-4-amine 1, a known cruzain inhibitor, were synthesized using a molecular simplification strategy. Five series of analogues were obtained: indole, pyrimidine, quinoline, aniline and pyrrole derivatives. The activity of the compounds was evaluated against the enzymes cruzain and rhodesain as well as against Trypanosoma cruzi amastigote and trypomastigote forms. The 4-aminoquinoline derivatives showed promising activity against both enzymes, with IC50 values ranging from 15 to 125 mu M. These derivatives were selective inhibitors for the parasitic proteases, being unable to inhibit mammalian cathepsins B and S. The most active compound against cruzain (compound 5a; IC50 =15 mu M) is considerably more synthetically accessible than 1, while retaining its ligand efficiency. As observed for the original lead, compound 5a was shown to be a competitive enzyme inhibitor. In addition, it was also active against T. cruzi (IC50 = 67.7 mu M). Interestingly, the pyrimidine derivative 4b, although inactive in enzymatic assays, was highly active against T. cruzi (IC50 = 3.1 mu M) with remarkable selectivity index (SI =128) compared to uninfected fibroblasts. Both 5a and 4b exhibit drug-like physicochemical properties and are predicted to have a favorable ADME profile, therefore having great potential as candidates for lead optimization in the search for new drugs to treat Chagas disease. (C) 2017 Elsevier Ltd. All rights reserved.
机译:使用分子简化策略合成8-氯-N-(3-丙基丙基)-5H-嘧啶[5,4-B] Indol-4-胺1,已知的克鲁松抑制剂的类似物。获得了五系列类似物:吲哚,嘧啶,喹啉,苯胺和吡咯衍生物。将化合物的活性对酶Cruzain和Rhodeain进行评估,以及对抗锥虫瘤Cruzi Amastigote和Trypomastigote形式。 4-氨基喹啉衍生物对两种酶进行有前途的活性,IC50值范围为15-125μm。这些衍生物是寄生虫蛋白酶的选择性抑制剂,无法抑制哺乳动物组织蛋白酶B和S.最活跃的化合物对Cruzain最活跃的化合物(化合物5a; IC50 =15μm)比1更大可合成可接近,同时保留其配体效率。如图所示,对于原始铅,化合物5a被显示为竞争性酶抑制剂。此外,它也对T.Cruzi(IC50 =67.7μm)有效。有趣的是,与未感染的成纤维细胞相比,嘧啶衍生物4b在酶促测定中的无活性,对于T.Cruzi(IC50 =3.1μm)具有显着的选择性指数(Si = 128)。图5A和4B均表现出类似的药物状物理化学性质,预计具有有利的Adme型材,因此具有较大的潜力作为在寻找新药物治疗钩抗病的新药中的候选者。 (c)2017 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号